In breast cancer, the expression of Shohl2 – a transcription factor of the bHLH family which inhibits EMT by repressing IL‐8 expression in vitro (Ji et al., 2016) – is reduced in metastases compared to primary tumors. Here, CXCL8 is linked to breast carcinoma.